Skip to search formSkip to main contentSkip to account menu

sulotroban

Known as: 4-(2-(benzenesulfonamido)ethyl)phenoxyacetic acid, Acetic acid, (4-(2-((phenylsulfonyl)amino)ethyl)phenoxy)- 
National Institutes of Health

Related topics

Related topics

6 relations

Broader (4)

Anti-Arrhythmia AgentsFibrinolytic AgentsPlatelet Aggregation InhibitorsSulfonamides

Narrower (2)

BM 13,177SK&F 95587

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
Thromboxane A2 Receptor Antagonism in Man and Rat by a Sulphonylcyanoguanidine (BM‐144) and a Sulphonylurea (BM‐500)
Torasemide, a loop diuretic, has been reported to relax dog coronary artery precontracted by thromboxane A2 (TXA2), an endogenous… 
1993
1993
A Study of the Use of the Thromboxane A2 Antagonist, Sulotroban, in Combination with Streptokinase for Local Thrombolysis in Patients with Recent Peripheral Arterial Occlusions: Clinical Effects…
Summary In peripheral thrombolysis adjuvant anti-platelet therapy may help to lyse otherwise resistant thrombus, thereby… 
1992
1992
Hirudin and sulotroban improve coronary blood flow after reperfusion induced by the novel recombinant plasminogen activator BM 06.022 in a canine model of coronary artery thrombosis.
Thrombus formation in anesthetized, open-chest dogs was induced by electrical injury to the intimal surface of the left… 
1992
1992
Effects of thromboxane agonists on cardiac adrenergic neurotransmission.
1992
1992
Influence of platelet-vessel wall interactions on leukocyte rolling in vivo.
The influence of platelet-vessel wall interactions on leukocyte rolling was investigated in rabbit mesenteric venules (diameter… 
1992
1992
Cyclic nucleotides and intracellular-calcium homeostasis in human platelets.
The relationship between agonist-sensitive calcium compartments and those discharged by the Ca(2+)-ATPase inhibitor thapsigargin… 
Review
1991
Review
1991
Multi-Hospital Eastern Atlantic Restenosis Trial. II: A placebo-controlled trial of thromboxane blockade in the prevention of restenosis following coronary angioplasty.
1990
1990
Does antiplatelet therapy enhance myocardial salvage after coronary reperfusion?
1989
1989
Sulotroban during and after coronary angioplasty. A double-blind, placebo controlled study.
Sulotroban, a sulphonamide derivative, causes an inhibition of platelet aggregation by blocking thromboxane A2 receptors. We… 
1988
1988
Irreversible inhibition of the TXA2/PGH2 receptor of human platelets by a photoaffinity ligand.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)